Motor neurone disease
- PMID: 12357010
- PMCID: PMC1742493
- DOI: 10.1136/pmj.78.923.513
Motor neurone disease
Abstract
Motor neurone disease (MND), or amyotrophic lateral sclerosis (ALS), is a neurodegenerative disorder of unknown aetiology. Progressive motor weakness and bulbar dysfunction lead to premature death, usually from respiratory failure. Confirming the diagnosis may initially be difficult until the full clinical features are manifest. For all forms of the disease there is a significant differential diagnosis to consider, including treatable conditions, and therefore specialist neurological opinion should always be sought. Clear genetic inheritance has been demonstrated in a minority of patients with familial ALS but elucidation of the biological basis of genetic subtypes is also providing important information which may lead to treatments for sporadic forms of the disease. In the absence of curative or disease modifying therapy, management is supportive and requires a multidisciplinary approach. If, as seems likely, complex inherited and environmental factors contribute to the pathogenesis of MND, future treatment may involve a combination of molecular based treatments or restoration of cellular integrity using stem cell grafts.
Similar articles
-
The future of motor neuron disease: the challenge is in the genes.J Neurol. 2004 Apr;251(4):491-500. doi: 10.1007/s00415-004-0322-6. J Neurol. 2004. PMID: 15083302 Review.
-
Motor neurone disease: a practical update on diagnosis and management.Clin Med (Lond). 2010 Jun;10(3):252-8. doi: 10.7861/clinmedicine.10-3-252. Clin Med (Lond). 2010. PMID: 20726457 Free PMC article.
-
Diagnostic investigation and multidisciplinary management in motor neuron disease.J Neurol. 2005 Dec;252(12):1435-47. doi: 10.1007/s00415-005-0007-9. J Neurol. 2005. PMID: 16362828 Review.
-
Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.J Neurol. 2000 Dec;247:7-12. J Neurol. 2000. PMID: 11200703 Review.
-
Evaluation and rehabilitation of patients with adult motor neuron disease.Arch Phys Med Rehabil. 1999 Aug;80(8):951-63. doi: 10.1016/s0003-9993(99)90089-8. Arch Phys Med Rehabil. 1999. PMID: 10453774 Review.
Cited by
-
Utility of Transcranial Magnetic Simulation in Studying Upper Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis.Brain Sci. 2021 Jul 9;11(7):906. doi: 10.3390/brainsci11070906. Brain Sci. 2021. PMID: 34356140 Free PMC article. Review.
-
Bim links ER stress and apoptosis in cells expressing mutant SOD1 associated with amyotrophic lateral sclerosis.PLoS One. 2012;7(4):e35413. doi: 10.1371/journal.pone.0035413. Epub 2012 Apr 16. PLoS One. 2012. PMID: 22523592 Free PMC article.
-
Diagnostic elements in amyotrophic lateral sclerosis: A case report.Biomed Rep. 2024 Aug 1;21(4):141. doi: 10.3892/br.2024.1829. eCollection 2024 Oct. Biomed Rep. 2024. PMID: 39161942 Free PMC article.
-
A comprehensive review of amyotrophic lateral sclerosis.Surg Neurol Int. 2015 Nov 16;6:171. doi: 10.4103/2152-7806.169561. eCollection 2015. Surg Neurol Int. 2015. PMID: 26629397 Free PMC article. Review.
-
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.PLoS Med. 2024 Oct 31;21(10):e1004469. doi: 10.1371/journal.pmed.1004469. eCollection 2024 Oct. PLoS Med. 2024. PMID: 39480764 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous